Is Vancevi a self-paid drug?

Valcyte (Valcyte, valganciclovir hydrochloride) is an antiviral drug mainly used to treat infections caused by cytomegalovirus (CMV). It is especially suitable for patients with suppressed immune function, such as patients who have received organ transplants or people infected with HIV (HIV). It plays an antiviral effect by inhibiting the DNA synthesis of the CMV virus.

Currently, Vancevir has been launched in China, but it has not yet been included in medical insurance. Due to its high price, patients are required to pay for it themselves when purchasing it, meaning it is a self-pay drug. According to market conditions, the domestic selling price of Wansaiwei is usually around more than 10,000 yuan. Specific prices will vary based on region, sales channel and pharmacy pricing. To ensure accurate pricing information, patients are advised to consult directly with their local hospital pharmacy.

Compared with domestic original drugs, the Indian and Turkish versions of Vancevir are relatively cheap, priced between three and four thousand yuan, and are basically the same as the domestic original drugs in terms of efficacy and ingredients. In addition, there are some generic drugs, such as the Lao version of generic drugs, which are relatively low-priced, about two thousand yuan. These versions of the drug are commonly found in international markets, especially for cost-sensitive patient groups.

Although Vancevi is already on the market in China, patients still have to pay for the drug as it is not covered by medical insurance. Patients can choose to purchase domestic original drugs or look for cheaper imported or generic drugs according to their own financial situation, but no matter which version they choose, it is best to use them under the guidance of a doctor.

xa0

Reference materials:

Roche official website https://www.roche.com

United StatesFDAOfficial website https://www.fda.gov